<?xml version="1.0" encoding="UTF-8"?><TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://publications.europa.eu/resource/schema/ted/R2.0.9/publication" xmlns:n2016="http://publications.europa.eu/resource/schema/ted/2016/nuts" xsi:schemaLocation="http://publications.europa.eu/resource/schema/ted/R2.0.9/publication TED_EXPORT.xsd" VERSION="R2.0.9.S03.E01" DOC_ID="471508-2020" EDITION="2020195"><TECHNICAL_SECTION><RECEPTION_ID>20-487243-001</RECEPTION_ID><DELETION_DATE>20210110</DELETION_DATE><FORM_LG_LIST>ES </FORM_LG_LIST><COMMENTS>From Convertor</COMMENTS></TECHNICAL_SECTION><LINKS_SECTION><XML_SCHEMA_DEFINITION_LINK xlink:type="simple" xlink:href="http://ted.europa.eu" xlink:title="TED WEBSITE"/><OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/></LINKS_SECTION><CODED_DATA_SECTION><REF_OJS><COLL_OJ>S</COLL_OJ><NO_OJ>195</NO_OJ><DATE_PUB>20201007</DATE_PUB></REF_OJS><NOTICE_DATA><NO_DOC_OJS>2020/S 195-471508</NO_DOC_OJS><URI_LIST><URI_DOC LG="ES">http://ted.europa.eu/udl?uri=TED:NOTICE:471508-2020:TEXT:ES:HTML</URI_DOC></URI_LIST><LG_ORIG>ES</LG_ORIG><ISO_COUNTRY VALUE="ES"/><IA_URL_GENERAL>http://www.madrid.org/contratospublicos</IA_URL_GENERAL><ORIGINAL_CPV CODE="33662000">Medicinal products for sensory organs</ORIGINAL_CPV><ORIGINAL_CPV CODE="33670000">Medicinal products for the respiratory system</ORIGINAL_CPV><ORIGINAL_CPV CODE="33661000">Medicinal products for the nervous system</ORIGINAL_CPV><ORIGINAL_CPV CODE="33652000">Antineoplastic and immunomodulating agents</ORIGINAL_CPV><ORIGINAL_CPV CODE="33622000">Medicinal products for the cardiovascular system</ORIGINAL_CPV><ORIGINAL_CPV CODE="33621000">Medicinal products for the blood and blood-forming organs</ORIGINAL_CPV><n2016:PERFORMANCE_NUTS CODE="ES300">Madrid</n2016:PERFORMANCE_NUTS><n2016:CA_CE_NUTS CODE="ES300">Madrid</n2016:CA_CE_NUTS><n2016:TENDERER_NUTS CODE="ES300">Madrid</n2016:TENDERER_NUTS><n2016:TENDERER_NUTS CODE="ES30">Comunidad de Madrid</n2016:TENDERER_NUTS><VALUES><VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="EUR">782656.10</VALUE></VALUES></NOTICE_DATA><CODIF_DATA><DS_DATE_DISPATCH>20201002</DS_DATE_DISPATCH><AA_AUTHORITY_TYPE CODE="3">Regional or local authority</AA_AUTHORITY_TYPE><TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE><NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE><PR_PROC CODE="T">Negotiated without a prior call for competition</PR_PROC><RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION><TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID><AC_AWARD_CRIT CODE="1">Lowest price</AC_AWARD_CRIT><MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES><HEADING>01B03</HEADING><INITIATOR>01</INITIATOR></CODIF_DATA></CODED_DATA_SECTION><TRANSLATION_SECTION><ML_TITLES><ML_TI_DOC LG="BG"><TI_CY>Иcпaния</TI_CY><TI_TOWN>Мадрид</TI_TOWN><TI_TEXT><P>Медикаменти за сетивните органи</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="CS"><TI_CY>Španělsko</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT><P>Léčivé přípravky pro smyslové orgány</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DA"><TI_CY>Spanien</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT><P>Lægemidler til sanseorganer</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DE"><TI_CY>Spanien</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT><P>Arzneimittel der Sinnesorgane</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EL"><TI_CY>Ισπανία</TI_CY><TI_TOWN>Μαδρίτη</TI_TOWN><TI_TEXT><P>Φάρμακα παθήσεων αισθητηρίων οργάνων</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EN"><TI_CY>Spain</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT><P>Medicinal products for sensory organs</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ES"><TI_CY>España</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT><P>Medicamentos para los órganos de los sentidos</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ET"><TI_CY>Hispaania</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT><P>Meeleelundite ravimid</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FI"><TI_CY>Espanja</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT><P>Silmä- ja korvatautien lääkkeet</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FR"><TI_CY>Espagne</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT><P>Médicaments des organes sensoriels</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="GA"><TI_CY>Spáinn, an</TI_CY><TI_TOWN>Maidrid</TI_TOWN><TI_TEXT><P>Medicinal products for sensory organs</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HR"><TI_CY>Španjolska</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT><P>Lijekovi za osjetilne organe</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HU"><TI_CY>Spanyolország</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT><P>Az érzékszervek gyógyszerei</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="IT"><TI_CY>Spagna</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT><P>Medicinali per gli organi sensoriali</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LT"><TI_CY>Ispanija</TI_CY><TI_TOWN>Madridas</TI_TOWN><TI_TEXT><P>Jutimo organus veikiantys vaistai</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LV"><TI_CY>Spānija</TI_CY><TI_TOWN>Madride</TI_TOWN><TI_TEXT><P>Zāles maņu orgāniem</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="MT"><TI_CY>Spanja</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT><P>Prodotti mediċinali għall-organi sensittorji</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="NL"><TI_CY>Spanje</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT><P>Geneesmiddelen voor zintuigelijke organen</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PL"><TI_CY>Hiszpania</TI_CY><TI_TOWN>Madryt</TI_TOWN><TI_TEXT><P>Produkty lecznicze dla organów zmysłów</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PT"><TI_CY>Espanha</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT><P>Medicamentos para os órgãos sensoriais</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="RO"><TI_CY>Spania</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT><P>Medicamente pentru organele senzoriale</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SK"><TI_CY>Španielsko</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT><P>Liečivá pre zmyslové orgány</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SL"><TI_CY>Španija</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT><P>Pripravki za zdravljenje bolezni čutil</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SV"><TI_CY>Spanien</TI_CY><TI_TOWN>Madrid</TI_TOWN><TI_TEXT><P>Läkemedel som verkar på sinnesorganen</P></TI_TEXT></ML_TI_DOC></ML_TITLES><ML_AA_NAMES><AA_NAME LG="ES">Servicio Madrileño de Salud — Hospital Central de la Cruz Roja San José y Santa Adela</AA_NAME></ML_AA_NAMES></TRANSLATION_SECTION><FORM_SECTION><F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="ES"><LEGAL_BASIS VALUE="32014L0024"/><CONTRACTING_BODY><ADDRESS_CONTRACTING_BODY><OFFICIALNAME>Servicio Madrileño de Salud — Hospital Central de la Cruz Roja San José y Santa Adela</OFFICIALNAME><NATIONALID>Q2877042H</NATIONALID><ADDRESS>Avenida Reina Victoria, 22, 8.ª planta</ADDRESS><TOWN>Madrid</TOWN><POSTAL_CODE>28003</POSTAL_CODE><COUNTRY VALUE="ES"/><CONTACT_POINT>Unidad de Contratación y Responsabilidad Patrimonial</CONTACT_POINT><PHONE>+34 914536557/685/438</PHONE><E_MAIL>contratacion.hccruzr@salud.madrid.org</E_MAIL><FAX>+34 914536525</FAX><n2016:NUTS CODE="ES300"/><URL_GENERAL>http://www.madrid.org/contratospublicos</URL_GENERAL><URL_BUYER>http://www.madrid.org/contratospublicos</URL_BUYER></ADDRESS_CONTRACTING_BODY><CA_TYPE VALUE="REGIONAL_AUTHORITY"/><CA_ACTIVITY VALUE="HEALTH"/></CONTRACTING_BODY><OBJECT_CONTRACT><TITLE><P>Suministro de medicamentos varios de distribución exclusiva</P></TITLE><REFERENCE_NUMBER>P.N.S.P HCCR-7/2020-SU</REFERENCE_NUMBER><CPV_MAIN><CPV_CODE CODE="33662000"/></CPV_MAIN><TYPE_CONTRACT CTYPE="SUPPLIES"/><SHORT_DESCR><P>Suministro de medicamentos varios por exclusividad para el Hospital Central de la Cruz Roja.</P></SHORT_DESCR><VAL_TOTAL CURRENCY="EUR">782656.10</VAL_TOTAL><LOT_DIVISION/><OBJECT_DESCR ITEM="1"><TITLE><P>Ranibizumab 10 mg/ml jeringa precargada 0,165 ml</P></TITLE><LOT_NO>1</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33662000"/></CPV_ADDITIONAL><n2016:NUTS CODE="ES300"/><SHORT_DESCR><P>Suministro de medicamentos varios de distribución exclusiva.</P></SHORT_DESCR><AC><AC_PRICE/></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="2"><TITLE><P>Omalizumab 150 mg inyect. 1 ml jeringa precargada</P></TITLE><LOT_NO>2</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33670000"/></CPV_ADDITIONAL><n2016:NUTS CODE="ES300"/><SHORT_DESCR><P>Suministro de medicamentos varios de distribución exclusiva.</P></SHORT_DESCR><AC><AC_PRICE/></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="3"><TITLE><P>Erenumab pluma precargada 140 mg</P></TITLE><LOT_NO>3</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33661000"/></CPV_ADDITIONAL><n2016:NUTS CODE="ES300"/><SHORT_DESCR><P>Suministro de medicamentos varios de distribución exclusiva.</P></SHORT_DESCR><AC><AC_PRICE/></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="4"><TITLE><P>Secukinumab 150 mg pluma precargada 1 ml</P></TITLE><LOT_NO>4</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33652000"/></CPV_ADDITIONAL><n2016:NUTS CODE="ES300"/><SHORT_DESCR><P>Suministro de medicamentos varios de distribución exclusiva.</P></SHORT_DESCR><AC><AC_PRICE/></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="5"><TITLE><P>Ustekinumab 45 mg jeringa precargada 0,5 ml</P></TITLE><LOT_NO>5</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33652000"/></CPV_ADDITIONAL><n2016:NUTS CODE="ES300"/><SHORT_DESCR><P>Suministro de medicamentos varios de distribución exclusiva.</P></SHORT_DESCR><AC><AC_PRICE/></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="6"><TITLE><P>Ustekinumab 130 mg inyectable 26 ml</P></TITLE><LOT_NO>6</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33652000"/></CPV_ADDITIONAL><n2016:NUTS CODE="ES300"/><SHORT_DESCR><P>Suministro de medicamentos varios de distribución exclusiva.</P></SHORT_DESCR><AC><AC_PRICE/></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="7"><TITLE><P>Ustekinumab 90 mg jeringa precargada 1 ml</P></TITLE><LOT_NO>7</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33652000"/></CPV_ADDITIONAL><n2016:NUTS CODE="ES300"/><SHORT_DESCR><P>Suministro de medicamentos varios de distribución exclusiva.</P></SHORT_DESCR><AC><AC_PRICE/></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="8"><TITLE><P>Guselkumab 100 mg pluma precargada 1 ml</P></TITLE><LOT_NO>8</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33652000"/></CPV_ADDITIONAL><n2016:NUTS CODE="ES300"/><SHORT_DESCR><P>Suministro de medicamentos varios de distribución exclusiva.</P></SHORT_DESCR><AC><AC_PRICE/></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="9"><TITLE><P>Ixekizumab 80 mg pluma precargada 1 ml</P></TITLE><LOT_NO>9</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33652000"/></CPV_ADDITIONAL><n2016:NUTS CODE="ES300"/><SHORT_DESCR><P>Suministro de medicamentos varios de distribución exclusiva.</P></SHORT_DESCR><AC><AC_PRICE/></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="10"><TITLE><P>Galcanezumab pluma 120 mg</P></TITLE><LOT_NO>10</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33661000"/></CPV_ADDITIONAL><n2016:NUTS CODE="ES300"/><SHORT_DESCR><P>Suministro de medicamentos varios de distribución exclusiva.</P></SHORT_DESCR><AC><AC_PRICE/></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="11"><TITLE><P>Mepolizumab 100 mg inyectable</P></TITLE><LOT_NO>11</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33670000"/></CPV_ADDITIONAL><n2016:NUTS CODE="ES300"/><SHORT_DESCR><P>Suministro de medicamentos varios de distribución exclusiva.</P></SHORT_DESCR><AC><AC_PRICE/></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="12"><TITLE><P>Alirocumab 75 mg pluma precargada 1 ml</P></TITLE><LOT_NO>12</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33622000"/></CPV_ADDITIONAL><n2016:NUTS CODE="ES300"/><SHORT_DESCR><P>Suministro de medicamentos varios de distribución exclusiva.</P></SHORT_DESCR><AC><AC_PRICE/></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="13"><TITLE><P>Tisseel solución adhesiva tisular 4 ml</P></TITLE><LOT_NO>13</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33621000"/></CPV_ADDITIONAL><n2016:NUTS CODE="ES300"/><SHORT_DESCR><P>Suministro de medicamentos varios de distribución exclusiva.</P></SHORT_DESCR><AC><AC_PRICE/></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="14"><TITLE><P>Hierro carboximaltosa 50 mg/ml iny. 20 ml</P></TITLE><LOT_NO>14</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33621000"/></CPV_ADDITIONAL><n2016:NUTS CODE="ES300"/><SHORT_DESCR><P>Suministro de medicamentos varios de distribución exclusiva.</P></SHORT_DESCR><AC><AC_PRICE/></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR><OBJECT_DESCR ITEM="15"><TITLE><P>Hierro carboximaltosa 50 mg/ml iny. 10 ml</P></TITLE><LOT_NO>15</LOT_NO><CPV_ADDITIONAL><CPV_CODE CODE="33621000"/></CPV_ADDITIONAL><n2016:NUTS CODE="ES300"/><SHORT_DESCR><P>Suministro de medicamentos varios de distribución exclusiva.</P></SHORT_DESCR><AC><AC_PRICE/></AC><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR></OBJECT_CONTRACT><PROCEDURE><PT_AWARD_CONTRACT_WITHOUT_CALL><D_ACCORDANCE_ARTICLE><D_PROTECT_RIGHTS/></D_ACCORDANCE_ARTICLE><D_JUSTIFICATION><P>Este es un procedimiento negociado sin publicidad por exclusividad.</P></D_JUSTIFICATION></PT_AWARD_CONTRACT_WITHOUT_CALL><CONTRACT_COVERED_GPA/></PROCEDURE><AWARD_CONTRACT ITEM="1"><CONTRACT_NO>19/20</CONTRACT_NO><LOT_NO>1, 2, 3, 4</LOT_NO><TITLE><P>Suministro de medicamentos de distribución exclusiva</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-09-22</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_EMEANS>1</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Novartis Farmacéutica, S. A.</OFFICIALNAME><TOWN>Madrid</TOWN><COUNTRY VALUE="ES"/><n2016:NUTS CODE="ES300"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">395499.58</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="2"><CONTRACT_NO>20/20</CONTRACT_NO><LOT_NO>5, 6, 7 8</LOT_NO><TITLE><P>Suministro de medicamentos varios de distribución exclusiva</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-09-22</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_EMEANS>1</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Janssen-Cilag, S. A.</OFFICIALNAME><TOWN>Madrid</TOWN><COUNTRY VALUE="ES"/><n2016:NUTS CODE="ES300"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">283013.32</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="3"><CONTRACT_NO>21/20</CONTRACT_NO><LOT_NO>9, 10</LOT_NO><TITLE><P>Suministro de medicamentos varios de distribución exclusiva</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-09-22</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_EMEANS>1</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Lilly, S. A.</OFFICIALNAME><TOWN>Madrid</TOWN><COUNTRY VALUE="ES"/><n2016:NUTS CODE="ES30"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">59610.80</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="4"><CONTRACT_NO>22/20</CONTRACT_NO><LOT_NO>11</LOT_NO><TITLE><P>Suministro de medicamentos varios de distribución exclusiva</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-09-22</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_EMEANS>1</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>GlaxoSmithKline, S. A.</OFFICIALNAME><TOWN>Madrid</TOWN><COUNTRY VALUE="ES"/><n2016:NUTS CODE="ES30"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">18925.72</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="5"><CONTRACT_NO>23/20</CONTRACT_NO><LOT_NO>12</LOT_NO><TITLE><P>Suministro de medicamentos varios de distribución exclusiva</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-09-22</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_EMEANS>1</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Sanofi-Aventis, S. A.</OFFICIALNAME><TOWN>Madrid</TOWN><COUNTRY VALUE="ES"/><n2016:NUTS CODE="ES30"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">1887.00</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="6"><CONTRACT_NO>24/20</CONTRACT_NO><LOT_NO>13</LOT_NO><TITLE><P>Suministro de medicamentos varios de distribución exclusiva</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-09-22</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_EMEANS>1</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Baxter, S. L.</OFFICIALNAME><TOWN>Madrid</TOWN><COUNTRY VALUE="ES"/><n2016:NUTS CODE="ES30"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">12451.20</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="7"><CONTRACT_NO>25/20</CONTRACT_NO><LOT_NO>14, 15</LOT_NO><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-09-22</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED><NB_TENDERS_RECEIVED_EMEANS>1</NB_TENDERS_RECEIVED_EMEANS></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Vifor Pharma España, S. L.</OFFICIALNAME><TOWN>Madrid</TOWN><COUNTRY VALUE="ES"/><n2016:NUTS CODE="ES30"/></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_TOTAL CURRENCY="EUR">11268.48</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><COMPLEMENTARY_INFO><ADDRESS_REVIEW_BODY><OFFICIALNAME>Tribunal Administrativo de Contratación Pública de la Comunidad de Madrid</OFFICIALNAME><TOWN>Madrid</TOWN><COUNTRY VALUE="ES"/></ADDRESS_REVIEW_BODY><ADDRESS_MEDIATION_BODY><OFFICIALNAME>Tribunal administrativo de Contratación Pública de la Comunidad de Madrid</OFFICIALNAME><TOWN>Madrid</TOWN><COUNTRY VALUE="ES"/></ADDRESS_MEDIATION_BODY><ADDRESS_REVIEW_INFO><OFFICIALNAME>Unidad de Contratación del Hospital Central de la Cruz Roja</OFFICIALNAME><TOWN>Madrid</TOWN><POSTAL_CODE>28003</POSTAL_CODE><COUNTRY VALUE="ES"/><PHONE>+34 914536685</PHONE><E_MAIL>contratacion.hccruzr@salud.madrid.org</E_MAIL><FAX>+34 914536525</FAX></ADDRESS_REVIEW_INFO><DATE_DISPATCH_NOTICE>2020-10-02</DATE_DISPATCH_NOTICE></COMPLEMENTARY_INFO></F03_2014></FORM_SECTION></TED_EXPORT>